Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapy

BACKGROUND: EPIC1 is an oncogenic long non-coding ribonucleic acid (RNA) that promotes cell growth and cell-cycle progression and inhibits apoptosis in several cancer cell lines. However, clinical studies on EPIC1 in breast cancer, specifically in the neoadjuvant setting, are relatively few. METHODS...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ther Adv Med Oncol
Main Authors: Xu, Yaqian, Wang, Yan, Yuan, Chenwei, Sheng, Xiaonan, Sha, Rui, Dai, Huijuan, Zhang, Shan, Wang, Yaohui, Lin, Yanping, Zhou, Liheng, Xu, Shuguang, Zhang, Jie, Yin, Wenjin, Lu, Jinsong
Formato: Artigo
Idioma:Inglês
Publicado: SAGE Publications 2020
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7383657/
https://ncbi.nlm.nih.gov/pubmed/32782487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920940886
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares